Key result
This letter discusses recent studies on prasugrel use in clopidogrel non-responders during neurointerventional procedures, highlighting the lack of standardized platelet testing methods.
Why the study?
Does prasugrel increase hemorrhagic complications compared to clopidogrel in neurointerventional patients who are clopidogrel non-responders?
Does prasugrel increase hemorrhagic complications compared to clopidogrel in neurointerventional patients who are clopidogrel non-responders?
No takes yet. Share an insight, caveat, or question.
This editorial highlights the challenges of defining clopidogrel non-responders and balancing thrombosis and hemorrhage risks with prasugrel in neurointerventional procedures.
Leslie‐Mazwi et al. (2012) conducted a letter in Suspected clopidogrel non-responders undergoing neurointerventional procedures. Prasugrel vs. Clopidogrel was evaluated on Hemorrhagic complications. This letter discusses recent studies on prasugrel use in clopidogrel non-responders during neurointerventional procedures, highlighting the lack of standardized platelet testing methods.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: